glp-1 white house Trump unveils deal to lower costs on obesity drugs Trump says U.S. to provide

Description

Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Por qu no me funciona el GLP-1

Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions

However, emerging research suggests that these medications may offer unexpected benefits for brain health, including improvements in addiction, depression, and cognitive function